Common Contracts
2 similar Exclusive License and Technology Transfer Agreement contracts by Advaxis, Inc.
EX-10.79 2 v367396_ex10-79.htm EX-10.79 Note: Portions of this document have been marked “[c.i.]” to indicate that confidential treatment has been requested for certain redacted confidential information. The confidential portions have been submitted...Exclusive License and Technology Transfer Agreement • May 5th, 2020 • New York
This EXCLUSIVE LICENSE AND TECHNOLOGY TRANSFER AGREEMENT (this “Agreement”), dated as of December 9, 2013 (the “Effective Date”), is made by and between Advaxis Inc. (“Advaxis”), a Delaware corporation, having its principal place of business at 305 College Road East, Princeton, New Jersey, and Global BioPharma, Inc. (“Licensee”), a corporation organized under the laws of Republic of China, having a place of business at 6F, No.10, LinSen S. Road, Taipei City, Taiwan, R.O.C. Advaxis and Licensee are individually referred to as a “Party” and collectively as the “Parties.”
EXCLUSIVE LICENSE AND TECHNOLOGY TRANSFER AGREEMENTExclusive License and Technology Transfer Agreement • February 6th, 2014 • Advaxis, Inc. • Pharmaceutical preparations • New York
Notwithstanding the foregoing, if Advaxis does not own any pending patent applications as of the Effective Date and listed on Schedule 1.27 or issued patents that Cover Products in a country within the Territory, the royalty shall be based on [c.i.] of Net Sales of Products sold in such country.
